TITLE:
Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

CONDITION:
HIV Infections

INTERVENTION:
APL 400-003

SUMMARY:

      The purpose of this study is to see if it is safe to give GENEVAX-HIV, a new HIV vaccine, to
      HIV-negative volunteers. This study will also look at how this vaccine affects the immune
      system of these volunteers.
    

DETAILED DESCRIPTION:

      In this open-label study, volunteers are given an intramuscular injection of GENEVAX-HIV
      vaccine using the Biojector 2000. Safety measures and immune response are assessed
      accordingly.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 60 Years
Criteria:

        Inclusion Criteria

        You may be eligible for this study if you:

          -  Are 18 - 60 years old.

          -  Are HIV-negative and in good health.

          -  Are able to understand how infections such as HIV are spread.

          -  Agree to use effective methods of birth control during the study.

        Exclusion Criteria

        You will not be eligible for this study if you:

          -  Have hepatitis B or C.

          -  Have any condition that may prevent you from completing the study.

          -  Are allergic to bupivacaine, vaccines, or certain local anesthetics.

          -  Have taken certain medications or have received certain therapies that may affect
             your immune system.

          -  Have an immune system disorder or have received therapy for an immune system
             disorder.

          -  Have been exposed to HIV within 6 months prior to study entry.

          -  Have received an experimental HIV vaccine or any other experimental treatment within
             30 days prior to study entry.

          -  Have received blood transfusions within 6 months prior to study entry.

          -  Abuse alcohol or drugs or have an uncontrolled psychiatric disorder.

          -  Are pregnant or breast-feeding.
      
